Home-based management of hypoxaemic COVID-19 patients: design of the Therapy@Home pilot study.
Josi A BoeijenAlma C van de PolRick T van UumRoderick P VenekampKarin SmitKarin A H KaasjagerRobert van den BroekWilma BijsterboschLisette SchoonhovenFrans H RuttenDorien L M ZwartPublished in: BMJ open (2024)
All patients will provide written, informed consent. The study was approved by the Medical Ethics Review Committee of the University Medical Center Utrecht, the Netherlands (protocol NL77421.041.21). The preparatory steps (1-4) needed to perform the pilot are executed and described in this paper. The findings of the pilot will be published in academic journals. If we consider the complex intervention feasible, we aim to continue with a large-scale randomised controlled study evaluating the clinical effectiveness, safety and implementation of the complex intervention.
Keyphrases
- randomized controlled trial
- study protocol
- healthcare
- end stage renal disease
- clinical trial
- ejection fraction
- chronic kidney disease
- newly diagnosed
- public health
- systematic review
- primary care
- meta analyses
- stem cells
- respiratory failure
- patient reported outcomes
- mesenchymal stem cells
- artificial intelligence
- patient reported
- deep learning